It has been shown that irradiated tumor cells in a vaccine expressing murine GM-CSF have been demonstrated to stimulate potent, long-lasting, and specific anti-tumor immunity, requiring both CD4+ and CD8+ cells [194]. Here, CD4 is linked to neoplasm.